In a noteworthy advancement for esophageal motility disorders, Dr. Sarath Chandra Gorantla has crossed a key clinical benchmark by completing more than 30 POEM procedures for patients with Achalasia Cardia since 2023. The achievement underscores the expanding role of advanced endoscopy in delivering durable, patient-centric solutions for complex gastrointestinal conditions.

POEM has transformed the therapeutic landscape of Achalasia Cardia. Unlike traditional surgical approaches, the technique employs a minimally invasive endoscopic route, enabling precise myotomy without external incisions. Patients benefit from lasting symptom relief, quicker recovery, and no visible scars, making POEM an increasingly preferred option for those struggling with swallowing difficulties.

Reflecting on the journey, Dr. Gorantla emphasizes the importance of precision endoscopy from thoughtful patient selection and meticulous dissection to comprehensive post-procedure follow-up. Across these cases, outcomes have been consistently gratifying, reinforcing the value of advanced endoscopic therapy within modern gastroenterology and hepatology practice.

Beyond technical success, each POEM case represents a meaningful improvement in daily life for patients living with Achalasia Cardia restoring comfort, confidence, and quality of life. Dr. Gorantla credits the trust of his patients and the dedication of his multidisciplinary team for making this milestone possible.